pharmacie et médicaments – Prise en charge des victimes de l'Androcur

This written question concerns the management of victims who suffered adverse effects from the drug Androcur. It seeks information on the current approach to their care and support within the pharmaceutical framework. The question addresses the responsibilities of healthcare providers and pharmaceutical companies, and asks about measures to ensure adequate compensation and treatment for affected individuals.